Investigación de nuevas estrategias terapeúticas para la inflamación y la fibrosis hepática.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  2010-04-30

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Ghrelin octanoylation mediated by an orphan lipid transferase

  2008cited by this paper
• CD95 ligand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells.

  2008cited by this paper
• Significance of chymase‐dependent angiotensin II formation in the progression of human liver fibrosis

  2008cited by this paper
• The TNF Superfamily-2008.

  2008cited by this paper
• Wnt Moves Beyond the Canon

  2008cited by this paper
• Toll‐like receptors and adaptor molecules in liver disease: Update

  2008cited by this paper
• High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate–activated protein kinase

  2008cited by this paper
• Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis.

  2008cited by this paper
• Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis.

  2008cited by this paper
• Mechanisms of hepatic fibrogenesis.

  2008cited by this paper
• Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats.

  2008cited by this paper
• Effect of Angiotensin-converting Enzyme Inhibition on Experimental Hepatic Fibrogenesis

  2008cited by this paper
• Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model

  2008cited by this paper
• Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis.

  2008cited by this paper
• IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.

  2007cited by this paper
• Inflammation, damage repair and liver fibrosis--role of cytokines and different cell types.

  2007cited by this paper
• Down-regulation of TGFβ1 and leptin ameliorates thioacetamide-induced liver injury in lipopolysaccharide-primed rats

  2007cited by this paper
• Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis

  2007cited by this paper
• Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation

  2007cited by this paper
• Mecanismos de lesión hepatocelular

  2007cited by this paper
• INHIBITION OF THE RENIN–ANGIOTENSIN SYSTEM ATTENUATES THE DEVELOPMENT OF LIVER FIBROSIS AND OXIDATIVE STRESS IN RATS

  2007cited by this paper
• G Protein regulation of MAPK networks

  2007cited by this paper
• TLR4 enhances TGF-beta signaling and hepatic fibrosis.

  2007cited by this paper
• Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury.

  2007cited by this paper
• Hypoxia induces the activation of human hepatic stellate cells LX‐2 through TGF‐β signaling pathway

  2007cited by this paper
• Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.

  2007cited by this paper
• CB1 cannabinoid receptor antagonism: A new strategy for the treatment of liver fibrosis

  2007cited by this paper
• Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis

  2007cited by this paper
• Adenosine monophosphate–activated protein kinase modulates the activated phenotype of hepatic stellate cells

  2007cited by this paper
• ACE2 of the heart: From angiotensin I to angiotensin (1-7).

  2007cited by this paper
• Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis.

  2007cited by this paper
• Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.

  2007cited by this paper
• NOX in liver fibrosis.

  2007cited by this paper
• The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention.

  2007cited by this paper
• Local Inhibition of Liver Fibrosis by Specific Delivery of a Platelet-Derived Growth Factor Kinase Inhibitor to Hepatic Stellate Cells

  2007cited by this paper
• Pro-fibrogenic potential of PDGF-D in liver fibrosis.

  2007cited by this paper
• Wnt signaling enhances the activation and survival of human hepatic stellate cells

  2007cited by this paper
• IFN-γ abrogates profibrogenic TGF-β signaling in liver by targeting expression of inhibitory and receptor Smads

  2007cited by this paper
• Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells.

  2007cited by this paper
• Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet.

  2007cited by this paper
• Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis

  2007cited by this paper
• Transforming Growth Factor-β1 Induces an Epithelial-to-Mesenchymal Transition State in Mouse Hepatocytes in Vitro*

  2007cited by this paper
• Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling

  2006cited by this paper
• Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats

  2006cited by this paper
• Toll-like receptor signaling in the liver.

  2006cited by this paper
• Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells.

  2006cited by this paper
• Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells.

  2006cited by this paper
• Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.

  2006cited by this paper
• Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development.

  2006cited by this paper
• Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways.

  2006cited by this paper
• Polymorphisms in the promoter region of the angiotensinogen gene are associated with liver cirrhosis in patients with chronic hepatitis B

  2006cited by this paper
• Delivery of the p38 MAPkinase inhibitor SB202190 to angiogenic endothelial cells: development of novel RGD-equipped and PEGylated drug-albumin conjugates using platinum(II)-based drug linker technology.

  2006cited by this paper
• Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro.

  2006cited by this paper
• STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity

  2006cited by this paper
• The impact of pregnane X receptor activation on liver fibrosis.

  2006cited by this paper
• Intracellular Delivery of the p38 Mitogen-Activated Protein Kinase Inhibitor SB202190 [4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H-imidazole] in Renal Tubular Cells: A Novel Strategy to Treat Renal Fibrosis

  2006cited by this paper
• Ghrelin gastrokinetic action in patients with neurogenic gastroparesis.

  2006cited by this paper
• Amelioration of liver fibrogenesis by dual inhibition of PDGF and TGF-beta with a combination of imatinib mesylate and ACE inhibitor in rats.

  2006cited by this paper
• Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology.

  2006cited by this paper
• Mechanisms of liver fibrosis.

  2006cited by this paper
• Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation.

  2006cited by this paper
• PPARγ Agonists Prevent TGFβ1/Smad3-Signaling in Human Hepatic Stellate Cells

  2006cited by this paper
• Effects of perindopril and valsartan on expression of transforming growth factor‐β‐Smads in experimental hepatic fibrosis in rats

  2006cited by this paper
• Therapeutic action of ghrelin in a mouse model of colitis.

  2006cited by this paper
• PI3K is involved in PDGF-beta receptor upregulation post-PDGF-BB treatment in mouse HSC.

  2006cited by this paper
• Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome.

  2006cited by this paper
• Interleukin-8 in the blood serum of patients with alcoholic liver disease.

  2006influential reference
• PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.

  2006cited by this paper
• Preproghrelin Leu72Met variant contributes to overweight in middle-aged men of a Japanese large cohort

  2006cited by this paper
• Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis.

  2006cited by this paper
• Rational Design of RGD–Albumin Conjugates for Targeted Delivery of the VEGF‐R Kinase Inhibitor PTK787 to Angiogenic Endothelium

  2006cited by this paper
• Antifibrogenic Effect of IFN-α2b on Hepatic Stellate Cell Activation by Human Hepatocytes

  2006cited by this paper
• Cytokines Promote Wnt Signaling and Inflammation and Impair the Normal Differentiation and Lipid Accumulation in 3T3-L1 Preadipocytes*

  2006cited by this paper
• Cytokines, STATs and liver disease.

  2005cited by this paper
• Treatment of cachexia with ghrelin in patients with COPD.

  2005cited by this paper
• Expression of angiotensin II type 1 receptor in human cirrhotic livers: Its relation to fibrosis and portal hypertension.

  2005cited by this paper
• Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells

  2005cited by this paper
• Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell.

  2005cited by this paper
• Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct–ligated rats

  2005cited by this paper
• Administration of ANG II induces iron deposition and upregulation of TGF-beta1 mRNA in the rat liver.

  2005cited by this paper
• SMAD and p38 MAPK Signaling Pathways Independently Regulate α1(I) Collagen Gene Expression in Unstimulated and Transforming Growth Factor-β-stimulated Hepatic Stellate Cells*

  2005cited by this paper
• ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-β1, PDGF-BB, NF-κB and MMP-2,9

  2005cited by this paper
• Endocannabinoids and liver disease

  2005cited by this paper
• Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.

  2005cited by this paper
• ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-beta1, PDGF-BB, NF-kappaB and MMP-2,9.

  2005cited by this paper
• Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms.

  2005cited by this paper
• Adipokines and liver fibrosis.

  2005cited by this paper
• Liver Fibrogenesis: A New Role for the Renin–Angiotensin System

  2005influential reference
• Angiotensin II Participates in Hepatic Inflammation and Fibrosis through MCP-1 Expression

  2005cited by this paper
• The Role of p70S6K in Hepatic Stellate Cell Collagen Gene Expression and Cell Proliferation*

  2005cited by this paper
• Ghrelin: structure and function.

  2005cited by this paper
• Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.

  2005influential reference
• Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice.

  2005cited by this paper
• Antifibrogenic role of the cannabinoid receptor CB2 in the liver.

  2005cited by this paper
• Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C

  2005cited by this paper
• Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury

  2004cited by this paper
• Differential requirement for c‐Jun NH2‐terminal kinase in TNF‐α‐and Fas‐mediated apoptosis in hepatocytes

  2004cited by this paper
• Liver fibrosis

  2004cited by this paper
• Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

  2004cited by this paper
• Prostaglandin E2 Inhibits Platelet-Derived Growth Factor-Stimulated Cell Proliferation Through a Prostaglandin E Receptor EP2 Subtype in Rat Hepatic Stellate Cells

  2004cited by this paper

• No citing papers are available for this paper.